Knome

Knome Inc. specializes in human genome interpretation systems and services that enable clients to uncover the genetic underpinnings of diseases, tumor growth, and responses to drugs. The company's knoSYS platform offers laboratories a comprehensive informatics infrastructure for analyzing and interpreting next-generation sequencing data, including alignment, variant calling, and storage of genomic sequences. Additionally, Knome provides the knomeDISCOVERY service, which supports pharmaceutical and academic researchers by facilitating the study of human exomes and whole genomes, offering guidance on study design, data management, and bioinformatics analysis. Knome's expertise spans various diseases, including cancer, autoimmune disorders, and neurodegenerative conditions. Founded in 2007 and based in Waltham, Massachusetts, Knome operates as a subsidiary of Tute Genomics, Inc., and has formed strategic partnerships to enhance its offerings in genomic interpretation and data analysis.